ERBB2 and breast cancer: Current studies have shown that HER2 over-expression exists in breast cancer, ovarian cancer, gastric cancer, prostate cancer and other tumors to varying degrees, and the size, stage, lymph node metastasis and prognosis of tumors are closely related to their expression intensity8.